GlassScriptPhysician profile
David B Kovacs
NPI 1861633083
$24,986.65
in general payments reported to CMS, 2019-2025
43 companies · $4,524 in 2025
The $4,524 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,788 · 2020: $803 · 2021: $945 · 2022: $3,987 · 2023: $4,736 · 2024: $5,204 · 2025: $4,524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $291 · Travel and Lodging: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,122.47 |
| Education | $290.97 |
| Travel and Lodging | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $4,920.52 | 2019-2025 | Enbrel, Otezla, Tavneos |
| Abbvie INC. | $4,579.35 | 2019-2025 | |
| Janssen Biotech, INC. | $1,969.04 | 2019-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $1,908.80 | 2019-2025 | |
| Ucb, INC. | $1,741.19 | 2019-2025 | Cimzia, Bimzelx |
| Lilly USA, LLC | $1,560.79 | 2019-2025 | Taltz, Zepbound |
| Glaxosmithkline, LLC. | $1,211.41 | 2019-2025 | Benlysta |
| Pfizer INC. | $1,025.05 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $762.49 | 2022-2025 | Ofev, Cyltezo, Jascayd |
| Astrazeneca Pharmaceuticals LP | $658.45 | 2021-2025 | Saphnelo |
| Horizon Therapeutics Plc | $471.18 | 2019-2023 | Krystexxa |
| Fresenius Kabi USA, LLC | $459.00 | 2023-2025 | |
| Radius Health, INC. | $454.30 | 2022-2025 | Tymlos |
| Aurinia Pharma U.S., INC. | $405.39 | 2022-2025 | Lupkynis |
| Celgene Corporation | $335.85 | 2019 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kovacs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.